Ralf Langhoff

Interventional angiologist, Head of Vascular Centre Berlin Alexianer St. Gertrauden-Hospital, Board Member of the German Society of Angiology, personal case load >20.000 cases, academic research primarily endovascular therapy

Anahita Dua, MD, MS, MBA, FACS, is a vascular surgeon at Massachusetts General Hospital and an associate professor of Surgery at Harvard Medical School. At Mass General, she is the co-director of the Peripheral Artery Disease Center and Limb Evaluation and Amputation Program (LEAPP), associate director of the Wound Care Center, clinical director of research, and associate director of the Vascular Surgery Clerkship.

She specializes in advanced endovascular (minimally invasive) and traditional (open) limb salvage techniques for treating peripheral arterial disease and critical limb ischemia, diabetic limb disease, aortic disease, carotid disease, thoracic outlet syndrome and venous disease.

Dr. Dua completed her vascular surgery fellowship at Stanford University Hospital and general surgery residency at the Medical College of Wisconsin. She has also completed a master’s degree in trauma sciences, a master’s in business administration in health care management and has a certificate in health economics/outcomes research as well as a certificate in drug and device development from the Massachusetts Institute of Technology. She is board-certified in vascular surgery, general surgery and advanced wound care and management.

Dr. Dua has published over 200 peer reviewed papers and has edited four vascular surgery medical textbooks. She serves on multiple national vascular surgery committees through the Society for Vascular Surgery and other vascular organizations including the South Asian-American Vascular Society and American College of Surgeons. Dr. Dua's NIH Funded lab focuses on anticoagulation and biomarkers that are predictive of thrombosis and hemostasis in patients that have undergone revascularization.

Dr. Elizabeth Genovese is an Assistant Professor of Surgery at the University of Pennsylvania and is the Director of the Penn Advanced Limb Preservation Program at the Hospital of the University of Pennsylvania. Dr. Genovese graduated from the University of Notre Dame, attended medical school at the University of Pittsburgh and completed her Integrated Vascular Surgery Residency at the University of Pittsburgh Medical Center, where she served as Chief Resident. Dr. Genovese specializes in advanced open and complex endovascular treatment of peripheral arterial disease, particularly chronic limb threatening ischemia. She currently serves as the Chair of the SUPRA INGUINAL and INFRA INGUINAL BYPASS VQI modules, and continues to participated in multiple local, regional and national societal committees. Her research focuses on healthcare disparities in peripheral arterial disease detection, treatment and outcomes, along with integration of new technology to streamline treatment algorithms and improve outcomes with complex endovascular therapies for peripheral arterial disease.

Interventional angiologist, Head of Vascular Centre Berlin Alexianer St. Gertrauden-Hospital, Board Member of the German Society of Angiology, personal case load >20.000 cases, academic research primarily endovascular therapy

Dr. Robert A. Lookstein, MD, MHCDL, FSIR, FAHA, FSVM,
A 1995 graduate of the State University of New York Downstate Health Sciences University College of Medicine, Dr. Lookstein honed his skills through a rigorous residency in diagnostic radiology and a fellowship in vascular and interventional radiology at Mount Sinai Hospital. His association with Mount Sinai has been both enduring and impactful, culminating in his current roles as Professor of Radiology and Surgery at the Icahn School of Medicine and Executive Vice Chairman of the Department of Diagnostic, Molecular, and Interventional Radiology for the Mount Sinai Health System .
Beyond his clinical and academic responsibilities, Dr. Lookstein is deeply invested in research that shapes the future of vascular care. He has been instrumental in several pivotal studies, including the VENITE VICI venous stent trial, the SAVAL study on drug-coated stents in lower leg arteries, the PRESERVE registry evaluating the safety and efficacy of Inferior Vena Cava filters, the InPACT AV trial evaluating the role of drug coated balloons for hemodialysis fistula maintenance, the STORM-PE trial evaluating the role of percutaneous thrombectomy for acute pulmonary embolism, and the NHLBI-funded BEST-CLI trial assessing endovascular revascularization for critical limb ischemia .
His leadership extends to the global stage, where he serves as the 2025–2026 President of the Society of Interventional Radiology (SIR). In this capacity, Dr. Lookstein advocates for a longitudinal clinical practice model in interventional radiology, emphasizing the importance of multidisciplinary teamwork and the integration of artificial intelligence to enhance patient outcomes .

Dr. Pradeep K. Nair, an interventional cardiologist, is Vice-Chairman of New Cardiovascular Horizons Conference in New Orleans, LA. He joined the Cardiovascular Institute of the South (CIS) in 2015. A native of Somerset Pennsylvania, he graduated with University Honors from Carnegie Mellon University and earned his medical doctorate at Drexel University College of Medicine. He completed his residency in internal medicine and fellowships in cardiovascular disease and interventional cardiology at the University of Pittsburgh Medical Center Presbyterian Campus where he was recognized with several awards of distinction for his cardiovascular research. He went on to complete a year of an advanced endovascular interventional fellowship under the mentorship of Craig Walker at the CIS in Houma, LA.

Dr. Nair is licensed by the State Board of Medicine in Pennsylvania and Louisiana. He is board certified in internal medicine, cardiovascular disease, interventional cardiology, nuclear cardiology and echocardiography. He currently practices in Houma, Gray and Zachary, Louisiana where he specializes in peripheral arterial/venous disease and interventions. He is a fellow of the American College of Cardiology (ACC) and the Society of Cardiac Angiography and Interventions. He serves Horizon's International Peripheral Group, Board of OEIS, ACC Vascular Disease Section Leadership Council, and CLI Global Society Publication Committee. He has authored multiple peer-reviewed publications, book chapters, and presented and performed Live Endovascular Cases at several cardiovascular meetings. Having a keen clinical research interest of novel interventional devices and therapies, he is dedicated to supporting the advancement of our field.

Interventional angiologist, Head of Vascular Centre Berlin Alexianer St. Gertrauden-Hospital, Board Member of the German Society of Angiology, personal case load >20.000 cases, academic research primarily endovascular therapy

Dr Konstantinos Katsanos finished his graduate studies in the School of Medicine, University of Patras, Greece in 2001, and continued his post-graduate studies and received an MSc degree in Pharmacology and Pharmacokinetics in 2006 and then a PhD thesis in 2009 in the field of therapeutic angiogenesis and arteriogenesis. He completed a subspecialty fellowship in Interventional Radiology in Guy's and St.Thomas' Hospitals, London, UK in 2008 and was among the first who sat for and received the European Boards in Interventional Radiology (EBIR) in late 2010 by the Cardiovascular and Interventional radiological Society of Europe (CIRSE). His current academic interests are focused on endovascular therapies of lower limb ischemia and failing dialysis access, as well as on interventional spine and vascular oncologic embolization procedures. He has already demonstrated a record of successful and productive basic and applied research. He has authored or co-authored more than 250 original papers in international peer-reviewed journals. In addition, he has presented numerous oral free papers and scientific presentations and has delivered numerous invited lectures in international conferences and symposia. He has been included in World’s Top 2% Scientists’ List by Stanford University.

Dr Kum received his medical degree from the National University of Singapore in 2000 and
subsequently embarked on his surgical training with the Royal College of Surgeons,
obtaining his Master of Medicine and Fellowship in 2007.
In 2009, he completed his Postgraduate Fellowship in Vascular and Endovascular Surgery at
the Prince of Wales Hospital, Sydney as well as at the Department of Angiology, Heart
Centre Leipzig. In 2012, he completed a second Fellowship on Advanced Techniques in
Diabetic Limb Salvage and Wound Care Techniques in Milan.
Since 2015, Dr Kum has been the Director of Vascular Surgery at Department of Surgery,
Changi General Hospital Singapore and he was subsequently appointed as a Visiting
Consultant in 2019. He currently maintains his practice at Mount Elizabeth Novena
Hospital, Singapore and is currently the CMO of M & L Healthcare. Dr Kum is the past President of the
Society for Vascular and Endovascular Surgeons of Singapore (SVESS) and is part of the organizing committee of
Critical Issues in Endovascular Therapy, a regional meeting organized by the society.
Dr Kum has a keen interest in clinical research revolving around Diabetic Limb Salvage. He is
one of the pioneers in Percutaneous Deep Arterialization for no-option Critical Limb
Ischemia for which he has authored or co-authored numerous papers. He is the PI or co-PI
for several industry or physician led studies. He is also a keen innovator who is currently
working on several disruptive technologies.

Interventional angiologist, Head of Vascular Centre Berlin Alexianer St. Gertrauden-Hospital, Board Member of the German Society of Angiology, personal case load >20.000 cases, academic research primarily endovascular therapy

Dr Lobato has been a Vascular and endovascular Surgery Consultant in Hospital Universitario de Cruces (Bilbao-Spain) since 2010. Her Department is considered a first line Unit in the Endovascular management of CLTI ( particularly in the BTK-BTA segments). She developed her Vascular Fellowship Programme in Hospital Universitario Doce de Octubre (Madrid) and thereafter completed her training with short stages in Hospital du Nord St Etienne (France), Universitäs Spital Zurich. (Switzerland), St Franziskus Hospital Münster.(Germany)
For the last ten years her activity has been mainly focused in the endovascular treatment of the lower limb,routinely performing complex CTO revascularizations, including any sort of bidirectional access, transcollateral approaches, plantar loop or venous arterialization. She is also a reviewer of the Critical Limb ischaemia Journal, Journal of Endovascular Therapy, Annals of Vascular Surgery, Journal of Cardiovascular Surgery and VASA European Jornal of Vascular Medicine. Her Unit has presented multiple communications in well recognized international symposiums and has published many papers in first line journals of her speciality

Jos C. van den Berg graduated from the Medical School of the State University of Leiden (NL) in 1986. The army was served in 1986-1988 as radiological resident at the Military Hospital "Dr. A. Mathijssen" in Utrecht (NL). In 1988 he started his radiology training program in the St. Radboud University Hospital, Nijmegen (NL). In 1994 he started working as an interventional radiologist at the Department of Radiology in the St. Antonius Hospital, Nieuwegein (NL) and since July 2001 he was Head of the Department of Radiology of this institution.
In July 2004 he started working as head of the Service of Interventional Radiology in the Ospedale Regionale di Lugano, Switzerland. He currently works in the Clinica Luganese Moncucco, Lugano, Switzerland and is associate professor of radiology (Privat Dozent) at the Medical Faculty of the University of Bern.
He has (co-)authored over 270 publications in peer-reviewed scientific journals and books.
He is Editor in Chief of the Journal of Critical Limb Ischemia reviewer, former Associate Editor of JVIR and member of the Editorial Board for European Radiology, EJVES, the Journal of Endovascular Therapy, CVIR Endovascular and JCVS and reviewer for JVIR, VASCULAR, JVS, EJR, Annals of Vascular Surgery, JIC, Acta Radiologica, JACC Cardiovascular Interventions, PlosOne, and CVIR. He is Board Member of the CLI Global Society and Chairman of the European Office of the CLI Global Society. He is Course Director of the AMP meeting in Chicago and AMP Europe, and Course Co-Director of the EVC meeting in Maastricht.

Professor Varcoe is a vascular surgeon at Sydney’s Prince of Wales Hospital where he is director of surgery, anaesthetics and perioperative services for the South Eastern Sydney Local Health District. He is also director of the Prince of Wales operating theatres and of the Vascular Institute, one of Australia’s most prestigious clinical trials centres. His clinical practice specialises in the minimally invasive treatment of aortic conditions, carotid disease and the full gamut of occlusive arterial disease of the lower limb for which he is internationally renowned.

He has a strong academic interest in novel stent and anastomotic technologies, the investigation of intimal hyperplasia, and cellular mechanisms, and has the first-in-man experience with the Absorb bioresorbable stent technology applied below-the-knee. In 2015, he completed his PhD and in 2020 he completed a Masters in Clinical Epidemiology focussing on clinical trial design and biostatistics at the University of Sydney.

He is a Professor at the University of New South Wales where he teaches regularly. He is founder and course director of the New South Wales Vascular meeting and the VERVE symposium, the largest annual endovascular summit in Australasia.

He is a member of numerous learned societies, has published more than 130 peer reviewed manuscripts, five book chapters, is an invited reviewer for multiple leading journal in the field of vascular medicine, intervention and science, is on the editorial board of several of those same journals. He has been invited to speak both nationally and internationally on more than 300 individual occasions.

Dr Ysa has been a Vascular and Endovascular Surgery Consultant in Hospital de Cruces (Barakaldo. Spain) since 2003. His Department is a well known institution in the endovascular management of CLTI patients. He developed his Vascular Fellowship Programme in Hospital del Mar (Barcelona. Spain) and thereafter completed his training with short stages in Montefiore Hospital (F. Veith. NY. USA) and Houston Methodist Hospital (TX. USA). In 2006 he became Fellow of the European Board of Vascular Surgery and in 2011 he joined St Mary´s Hospital (London. UK) as a Senior Specialist Registrar.
For the last ten years his activity has been mainly focussed in the endovascular treatment of the lower limbs, being the co-director of the complex BTK/BTA revascularization Unit of his Department. He is also a reviewer of the Annals of Vascular Surgery and Journal of Endovascular Therapy since 2008 and 2019.
His Unit has presented multiple communications in well-recognized international symposiums and has published many papers in first-line journals of his specialty. In 2020, his clip “ Proximal venous arterialization using conventional “off-the-shelf” devices” was awarded as the most innovative video of the European Society in Vascular Surgery Masterclass.

Marianne Brodmann, MD, Prof is a vascular specialist at the Medical University of Graz, Austria. She has been trained in Internal Medicine at the University Hospital of Graz and her main focus, after specializing in Vascular Medicine (Angiology), is doing peripheral endovascular procedures. She is involved in many trials dealing with new endovascular techniques in both claudicants as well as CLI patients.